President Moon: "Producing Our Vaccines with Our Technology Is a National Goal"

Meeting with CEPI Representative... "SK Bioscience's Phase 2 Clinical Trial Highly Successful"

[Asia Economy Reporter Ryu Jeong-min] On the 16th, President Moon Jae-in met with Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), at the Blue House and stated, "We are making it a national goal to develop and produce our own vaccines using our own technology."

President Moon said, "In particular, looking at the results of the Phase 2 clinical trial of the vaccine developed by SK Bioscience, which CEPI and the Korean government are jointly supporting, it appears to be very successful, so expectations are high."

President Moon added, "There is still the Phase 3 trial ahead, and I ask CEPI to maintain its interest until the very end so that we can succeed in development."

[Image source=Yonhap News]

President Moon evaluated, "CEPI played a truly important and significant role in responding to this COVID-19 pandemic. Thanks to CEPI's bold support for vaccine development and the determination of its CEO, we succeeded in developing vaccines at an unprecedented speed, which has protected many human lives."

President Moon said, "I think this is a model case of global cooperation on infectious diseases. Korea also joined CEPI last year and is actively cooperating," adding, "Korea is contributing by contract manufacturing various types of vaccines."

Hatchett, CEPI CEO, said, "Korea was the first Asian country to be visited since the pandemic outbreak," and evaluated, "It was very impressive how the Korean government and people mobilized all their capabilities to respond successfully to the infectious disease COVID-19."

[Image source=Yonhap News]

CEO Hatchett said, "I believe Korea has set a global standard. Especially in responding very quickly and systematically to the infectious disease COVID-19, I think Korea established such standards," adding, "The number of confirmed COVID-19 cases and deaths in Korea is remarkably low compared to countries of similar size."

CEO Hatchett explained, "Korea is well known as a hub for science and technology," and said, "By working with Korean companies such as SK Bioscience and Green Cross Corporation, significant progress has been made in developing and distributing COVID-19 vaccines."

This content was produced with the assistance of AI translation services.